Avendus Capital advises HealthKart, India’s leading consumer nutrition platform, on its USD 135 million fundraise from Temasek and A91 Partners

We are delighted to partner with Temasek and A91 Partners in our mission to deliver innovative, high quality, yet affordable preventive care solutions to Indian consumers. Driving fitness and preventive health by addressing the nutritional gaps is a systemic trend which is taking off in a big way in India. With HealthKart’s R&D capabilities and omni-channel distribution infrastructure, we are excited to lead the way.

HealthKart has the opportunity to build the largest and most significant consumer brand in the health and nutritional space. It is a digital first pioneer which has successfully transitioned into an omni-channel business, and achieved market leadership in the past five years in the segments it operates in. We are excited to support Sameer and his team as they double down on their core offering and expand the health and supplement basket to new categories (high protein food) and new customers (kids).

HealthKart is India's only vertically focussed D2C nutrition platform. It aims to bridge the nutritional needs of the ever expanding health-conscious India. Sameer and the HealthKart team have established strong awareness and customer trust with marquee brands like MuscleBlaze, HK Vitals, amongst others. With the growing awareness of health and wellness, HealthKart is best positioned to capitalize on the massive opportunity ahead. It has been a privilege to partner with them on one of the largest transactions in the Healthcare and D2C vertical.